🇺🇸 FDA
Patent

US 8058257

Compositions and methods for inhibiting expression of a gene from the JC virus

granted A61KA61K48/005A61P

Quick answer

US patent 8058257 (Compositions and methods for inhibiting expression of a gene from the JC virus) held by Alnylam Pharmaceuticals, Inc. expires Mon Nov 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Alnylam Pharmaceuticals, Inc.
Grant date
Tue Nov 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K48/005, A61P, A61P25/28, A61P31/12